title: LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
abstract: Collaborative regulation of liver X receptor (LXR) and sterol regulatory element binding protein (SREBP)-1 are main determinants in hepatic steatosis, as shown in both animal models and human patients. Recent studies indicate that selective intervention of overly functional LXRα in the liver shows promise in treatment of fatty liver disease. In the present study, we evaluated the effects of meso-dihydroguaiaretic acid (MDGA) on LXRα activation and its ability to attenuate fatty liver in mice. MDGA inhibited activation of the LXRα ligand-binding domain by competitively binding to the pocket for agonist T0901317 and decreased the luciferase activity in LXRE-tk-Luc-transfected cells. MDGA significantly attenuated hepatic neutral lipid accumulation in T0901317- and high fat diet (HFD)-induced fatty liver. The effect of MDGA was so potent that treatment with 1mg/kg for 2 weeks completely reversed the lipid accumulation induced by HFD feeding. MDGA reduced the expression of LXRα co-activator protein RIP140 and LXRα target gene products associated with lipogenesis in HFD-fed mice. These results demonstrate that MDGA has the potential to attenuate nonalcoholic steatosis mediated by selective inhibition of LXRα in the liver in mice.
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: Woo-Cheol
authors: WC
authors: Sim
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: Sora
authors: S
authors: Park
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: Kang-Yo
authors: KY
authors: Lee
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: Young-Tae
authors: YT
authors: Je
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: Hu-Quan
authors: HQ
authors: Yin
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: You-Jin
authors: YJ
authors: Choi
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea.
authors: Sang Hyun
authors: SH
authors: Sung
authors: School of Pharmacy, Sungkyunkwan University, Seobu-ro 2066, Jangan-gu, Suwon 440-746, Republic of Korea.
authors: So-Jung
authors: SJ
authors: Park
authors: School of Pharmacy, Sungkyunkwan University, Seobu-ro 2066, Jangan-gu, Suwon 440-746, Republic of Korea.
authors: Hyun-Ju
authors: HJ
authors: Park
authors: College of Pharmacy, The Catholic University, Bucheon 420-743, Republic of Korea.
authors: Kye Jung
authors: KJ
authors: Shin
authors: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 151-742, Republic of Korea. Electronic address: lee@snu.ac.kr.
authors: Byung-Hoon
authors: BH
authors: Lee
mesh_terms: D000818:Animals; D001483:Base Sequence; D045744:Cell Line, Tumor; D017931:DNA Primers; D059305:Diet, High-Fat; D005234:Fatty Liver / Q000517:prevention & control*; D006139:Guaiacol / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D017705:Lignans / Q000494:pharmacology*; D050155:Lipogenesis / Q000187:drug effects; D000071518:Liver X Receptors; D051379:Mice; D008810:Mice, Inbred C57BL; D062105:Molecular Docking Simulation; D065626:Non-alcoholic Fatty Liver Disease; D057093:Orphan Nuclear Receptors / Q000037:antagonists & inhibitors*
chemical_list: D017931:DNA Primers; D017705:Lignans; D000071518:Liver X Receptors; C000605213:NR1H3 protein, human; C000605214:Nr1h3 protein, mouse; D057093:Orphan Nuclear Receptors; C015816:dihydroguaiaretic acid; D006139:Guaiacol
keywords: 22S-hydroxycholesterol (PubChem CID: 168038); GW4064 (PubChem CID: 9893571); Geranylgeranylpyrophosphate (PubChem CID: 44134732); Liver X receptor α (LXRα); Nonalcoholic fatty liver disease (NAFLD); Receptor interacting protein 140 (RIP140); Reverse cholesterol transport; Rifampicin (PubChem CID: 5381226); Sterol-response element binding protein 1c (SREBP1c); T0901317 (PubChem CID: 447912); meso-Dihydroguaiaretic acid (PubChem CID: 476856)